Alx Oncology SVP Shelly Wong sells $1,105 of company stock

Senior Vice President of Finance and Chief Accounting Officer at ALX Oncology Holdings Inc., Shelly Wong, sold 573 shares of the company's common stock on August 17, 2026. The sale, valued at $1,105, was conducted to satisfy tax obligations linked to the vesting of restricted stock units. The shares were sold at $1.93 per share, bringing the company's stock price to $2.08 today, marking a substantial 114% increase over the previous year.

ALXO's stock is currently trading near its Fair Value of $2.03, according to InvestingPro analysis. The company, however, is rapidly depleting its cash reserves, a concern highlighted by one of the additional ProTips accessible to subscribers. Post this transaction, Ms. Wong still holds 87,828 shares of ALX Oncology Holdings Inc. common stock.

Recently, ALX Oncology Holdings Inc. has undergone notable changes in its leadership. Scott Garland has assumed the role of Chairman of the Board of Directors, taking over from co-founder Corey Goodman, who stepped down after a decade-long tenure with the company. Garland, who has been a board member since November 2022, brings over three decades of experience in the biopharmaceutical sector.

Additionally, Michael Listgarten has been appointed as the new General Counsel. These leadership changes signal a significant shift in the company's governance structure.